Hello, I'm Greg Jenna and good news, Your Dead to Me is back for a new series. Here we go. Yes, we'll explore Emperor Nero's notorious reign with Professor Marybeard and Patton Oswald. I would not want my daughter having the remote control, not alone an empire. We'll dissect the decadent life of Philippe Duke-Dor-Leon with Tom Allen. I've often tried to pretend I'm an aristocrat and being very quickly knocked down. And there'll be so much more with comedians like Olga Koch, Mike Mosniak and Rihalina. I'm excited. You're dead to me, the comedy podcast that takes history seriously. Listen first on BBC Sounds. Hello, thank you for listening to this edition of Inside Health. I hope you enjoy it. Coming up today, irritable bowel syndrome and a new service for helping people with IBS that hasn't responded to the standard treatments.

And it all centres on what and how you eat.

A finger-prick test that can tell you whether you need antibiotics.

It's been more than two years since

Nice endorse the use of CRP testing to help doctors assess people with chest infections. So,

why is hardly anyone using the technology? And I eat humble pie, having been castigated

for getting clinical trial terminology mixed up.

But first, osteoporosis, a new research suggesting that the bisphosphonate family of drugs,

currently the first-line treatment for the condition, may actually weaken rather than strengthen bones.

It was a tiny study, including just 16 people, but it hit the headlines.

The team from Imperial College London found that the bones of people with osteoporosis,

given bisphosphonates, contained lots of tiny faults or micro-fractures

that made them weaker than the bones of people with untreated osteoporosis.

The drugs are taken by hundreds of thousands of people in the UK

and the resulting media coverage has caused concern.

Peter Selby is Professor of Metabolic Bone Disease at the University of Manchester

and joined us on the internet from Manchester Royal Infirmary.

Peter, it's no wonder people are worried these drugs are supposed to strengthen weakened bone and protect against fractures.

I think that's a real concern.

And I think for some years now, we've known that when we've been treating people with this type of drug,

we've been walking a little bit of a tightrope.

So on the one hand, we're very anxious to stop the body breaking down bone, losing bone too quickly.

...